- /
- Supported exchanges
- / TO
- / HLS.TO
HLS Therapeutics Inc (HLS TO) stock market data APIs
HLS Therapeutics Inc Financial Data Overview
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally. The company offers Clozaril (clozapine tablets), an atypical antipsychotic to manage symptoms of treatment-resistant schizophrenia; CSAN Pronto device, which enhances and simplifies the mandatory safety blood monitoring process for patients that are prescribed Clozaril; Nilemdo, a bempedoic acid product for cardiovascular risk reduction; Nexlizet, a bempedoic acid and ezetimibe product for cardiovascular risk reduction; and Vascepa, an icosapent ethyl capsule for the treatment of cardiovascular disease. It also distributes MyCare psychiatry lab assays, which are a line of tests that can be processed on analyzers used in laboratory systems to measure the blood levels of the most common antipsychotic drugs, including clozapine, risperidone, quetiapine, aripiprazole, olanzapine, and paliperidone; and MyCare Insite, a point-of-care device that requires only a single drop of blood taken by a finger stick to measure patient drug levels. In addition, the company holds royalty interest in Takeda's Obizur, a porcine recombinant Factor VIII for acquired Hemophilia A. It serves wholesalers and institutions. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with HLS Therapeutics Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get HLS Therapeutics Inc data using free add-ons & libraries
Get HLS Therapeutics Inc Fundamental Data
HLS Therapeutics Inc Fundamental data includes:
- Net Revenue: 56 243 K
- EBITDA: 17 010 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-11-12
- EPS/Forecast: -0.08
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
HLS Therapeutics Inc News
New
HLS Therapeutics Announces Q3 2026 Financial Results
Q3 revenue of $14.2 million, up 5% year-over-year; Adjusted EBITDA of $5 million, up 1% year-over-year Cardiovascular portfolio net sales grew 21% year-over-year in local currency, with NILEMDO™ net...
HLS Therapeutics Partners with Bayer to Commercialize VERQUVO® in Canada
VERQUVO® is authorized and available in Canada, with public and private reimbursement in place. VERQUVO® is an oral treatment indicated for symptomatic chronic heart failure. HLS will assume respons...
HLS Therapeutics Announces Board of Directors Changes
TORONTO, Oct. 1, 2026 /CNW/ -- HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS) announces the appointment of Linda Maxwell, M.D. and Mark DeLong as independent directors to its Board of Direc...
HLS Therapeutics Q1 Earnings Call Highlights
Key Points Interested in HLS Therapeutics Inc.? Here are five stocks we like better. HLS reported Q1 revenue of $12.9 million, up 2% year over year, and reaffirmed its 2026 guidance for revenue of $5...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.